These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25595701)

  • 1. Discontinuing inhaled steroids might not be safe in severe COPD cases.
    Laniado-Laborín R
    Evid Based Med; 2015 Apr; 20(2):57. PubMed ID: 25595701
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhaled glucocorticoids and COPD exacerbations.
    Cosio M; Baraldo S; Saetta M
    N Engl J Med; 2015 Jan; 372(1):92. PubMed ID: 25551536
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP journal club. For preventing exacerbations of COPD, withdrawal of inhaled glucocorticoids was noninferior to continuation.
    Stanbrook MB
    Ann Intern Med; 2015 Mar; 162(6):JC5. PubMed ID: 25775348
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhaled glucocorticoids and COPD exacerbations.
    Brightling CE; Pavord ID; Bafadhel M
    N Engl J Med; 2015 Jan; 372(1):93. PubMed ID: 25551538
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhaled glucocorticoids and COPD exacerbations.
    Singanayagam A; Johnston SL; Mallia P
    N Engl J Med; 2015 Jan; 372(1):92-3. PubMed ID: 25551537
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhaled glucocorticoids and COPD exacerbations.
    Magnussen H; Tetzlaff K; Calverley PM
    N Engl J Med; 2015 Jan; 372(1):93-4. PubMed ID: 25551535
    [No Abstract]   [Full Text] [Related]  

  • 7. Stepping down therapy in COPD.
    Reilly JJ
    N Engl J Med; 2014 Oct; 371(14):1340-1. PubMed ID: 25196116
    [No Abstract]   [Full Text] [Related]  

  • 8. The INSPIRE study: influence of prior use and discontinuation of inhaled corticosteroids.
    Lanes SF; Jara M
    Am J Respir Crit Care Med; 2008 Sep; 178(5):543-4; author reply 544. PubMed ID: 18713851
    [No Abstract]   [Full Text] [Related]  

  • 9. Withdrawal of inhaled glucocorticoids and exacerbations of COPD.
    Magnussen H; Disse B; Rodriguez-Roisin R; Kirsten A; Watz H; Tetzlaff K; Towse L; Finnigan H; Dahl R; Decramer M; Chanez P; Wouters EF; Calverley PM;
    N Engl J Med; 2014 Oct; 371(14):1285-94. PubMed ID: 25196117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD.
    Maltais F; Mahler DA; Pepin V; Nadreau E; Crater GD; Morris AN; Emmett AH; Ferro TJ
    Eur Respir J; 2013 Aug; 42(2):539-41. PubMed ID: 23904549
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evidence of pharmacotherapy in COPD--key findings from recently-conducted randomized clinical studies].
    Shimizu K; Nishimura M
    Nihon Rinsho; 2011 Oct; 69(10):1815-20. PubMed ID: 22073579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of airway dimensions with once daily tiotropium plus indacaterol versus twice daily Advair(®) in chronic obstructive pulmonary disease.
    Hoshino M; Ohtawa J; Akitsu K
    Pulm Pharmacol Ther; 2015 Feb; 30():128-33. PubMed ID: 25183687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient management of severe COPD.
    Singh S; Loke YK; Furberg CD
    N Engl J Med; 2010 Jul; 363(5):493-4; author reply 494-5. PubMed ID: 20666630
    [No Abstract]   [Full Text] [Related]  

  • 14. ACP Journal Club. Review: inhaled medications vary substantively in their effects on mortality in COPD.
    Shafazand S
    Ann Intern Med; 2013 Jun; 158(12):JC2. PubMed ID: 23778926
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD.
    Najafzadeh M; Marra CA; Sadatsafavi M; Aaron SD; Sullivan SD; Vandemheen KL; Jones PW; Fitzgerald JM
    Thorax; 2008 Nov; 63(11):962-7. PubMed ID: 18621985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple inhaler therapy for COPD.
    Lipworth B
    Thorax; 2015 Oct; 70(10):991. PubMed ID: 26092923
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-acting inhaled bronchodilators for COPD--lack of logic continues.
    Jones D
    N Z Med J; 2005 Sep; 118(1222):U1669. PubMed ID: 16222360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD.
    Rabe KF; Timmer W; Sagkriotis A; Viel K
    Chest; 2008 Aug; 134(2):255-262. PubMed ID: 18403672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do we need three players in COPD treatment?
    Maestrelli P; Mason P; Costa F; Paggiaro P
    Respiration; 2013; 86(4):275-6. PubMed ID: 23988429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.